NorthCrest Asset Manangement LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 7.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,760 shares of the healthcare conglomerate's stock after acquiring an additional 1,427 shares during the period. NorthCrest Asset Manangement LLC's holdings in UnitedHealth Group were worth $9,996,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Norges Bank purchased a new stake in UnitedHealth Group during the 4th quarter worth about $6,375,744,000. Raymond James Financial Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $1,914,740,000. Amundi boosted its position in UnitedHealth Group by 97.2% during the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock worth $3,183,132,000 after acquiring an additional 2,991,470 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after purchasing an additional 2,301,010 shares during the period. Finally, Proficio Capital Partners LLC increased its stake in UnitedHealth Group by 76,830.4% in the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate's stock valued at $955,388,000 after purchasing an additional 1,886,186 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several research firms recently issued reports on UNH. Robert W. Baird decreased their target price on shares of UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 14th. Truist Financial reaffirmed a "buy" rating and issued a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Wells Fargo & Company dropped their price target on UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. Finally, Argus downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. One analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $441.87.
Read Our Latest Research Report on UNH
Insider Buying and Selling at UnitedHealth Group
In related news, CFO John F. Rex purchased 17,175 shares of the company's stock in a transaction dated Friday, May 16th. The shares were acquired at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the transaction, the chief financial officer now owns 203,796 shares of the company's stock, valued at $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Stephen J. Hemsley bought 86,700 shares of the company's stock in a transaction on Friday, May 16th. The stock was bought at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the transaction, the chief executive officer now directly owns 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired a total of 109,408 shares of company stock worth $31,607,768 over the last 90 days. Insiders own 0.33% of the company's stock.
UnitedHealth Group Stock Up 1.0%
Shares of NYSE:UNH traded up $2.91 during midday trading on Friday, reaching $301.08. The company had a trading volume of 16,265,624 shares, compared to its average volume of 6,787,922. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a market capitalization of $273.12 billion, a P/E ratio of 19.42, a PEG ratio of 1.37 and a beta of 0.56. The stock's fifty day moving average price is $430.87 and its 200-day moving average price is $494.23.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the previous year, the company earned $6.91 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report